首页|期刊导航|中国体外生命支持|血浆游离血红蛋白与部分凝血活酶时间联合评价血泵机械溶血的研究

血浆游离血红蛋白与部分凝血活酶时间联合评价血泵机械溶血的研究OA

Combined Assessment of Plasma Free Hemoglobin and Partial Thromboplastin Time for Evaluating Mechanical Hemoly-sis in Blood Pumps

中文摘要英文摘要

目的 研究血泵循环过程中产生的血浆游离血红蛋白(PFH)与部分凝血活酶时间(PTT)之间的动态关系,建立一种更为全面的血泵机械溶血的评价方法.方法 模拟血泵的临床使用方法,使用新鲜抗凝牛血建立体外血液循环回路,检测不同流量下运行1、2、3、4、5、6 h的PFH及PTT.结果 随着泵流量和时间的增加,PFH呈正相关趋势,PTT呈负相关趋势,两者之间通过Spearman秩相关分析存在强负相关(r=-0.78,P<0.001).结论 当血泵机械力介导出现溶血时,PFH升高与PTT缩短具有一致且稳定的负相关趋势.虽尚不能确立直接因果关系,但同步监测PFH与PTT可更全面识别体外循环中的血液损伤风险,优化血泵类医疗器械的血液相容性评价.

Objective To investigate the dynamic relationship between plasma free hemoglobin(PFH)and partial thromboplastin time(PTT)during blood pump circulation,and to establish a more comprehensive evaluation method for me-chanical hemolysis.Methods To simulate clinical application of blood pumps,an extracorporeal blood circulation circuit was established using fresh anticoagulated bovine blood.PFH and PTT were measured at 1,2,3,4,5,and 6 h under various pump flow rates.Results PFH showed a positive correlation with increasing pump flow rates and circulation duration,whereas PTT showed a negative correlation.Spearman rank correlation analysis revealed a strong negative correlation between PFH and PTT(r=-0.78,P<0.001).Conclusion Mechanical force-induced hemolysis in blood pumps is associated with a consistent and sta-ble negative correlation between elevated PFH and shortened PTT.Although a direct causal relationship cannot be established,simultaneous monitoring of PFH and PTT may provide a more comprehensive identification of blood injury risks during extra-corporeal circulation and improve the hemocompatibility evaluation of blood pump medical devices.

莫晓彦;柯军;徐苏华;吴雅琳;郝文茜;叶嘉莉;杨文润

广东省医疗器械质量监督检验所,广州 510080广东省医疗器械质量监督检验所,广州 510080广东省医疗器械质量监督检验所,广州 510080广东省医疗器械质量监督检验所,广州 510080广东省医疗器械质量监督检验所,广州 510080广东省医疗器械质量监督检验所,广州 510080广东省医疗器械质量监督检验所,广州 510080

医疗器械血泵机械溶血血浆游离血红蛋白部分凝血活酶时间血液相容性

medical devicesblood pumpsmechanical hemolysisplasma free hemoglobinpartial thromboplastin timehemocompatibility

《中国体外生命支持》 2026 (4)

337-341,5

广东省药品监督管理局科技创新项目(2026TDZ33)

10.13498/j.cnki.chin.j.ecls.2026.04.12

评论